Yes, the microbiome can significantly impact the effectiveness and toxicity of cancer treatments. For example, the gut microbiome can affect how patients respond to chemotherapy and immunotherapy. Certain bacteria can metabolize drugs, altering their efficacy or causing adverse side effects. Conversely, a favorable microbiome composition might improve treatment outcomes by enhancing immune function and reducing therapy-related toxicity.
